Skip to main content

Cerezyme 400 units injectable infusion

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CEREZYME 400 units powder for concentrate for infusion solution

Contents of the leaflet

  1. Introduction
  2. What is Cerezyme and what is it used for
  3. What you need to know before you are given Cerezyme
  4. How Cerezyme is given
  5. Possible side effects
  6. How to store Cerezyme
  7. Contents of the pack and other information

Introduction

Package Leaflet:information for the user

Cerezyme 400Units powder for concentrate for solution for infusion

Imiglucerase

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Cerezyme and what is it used for
  2. What you need to know before you are given Cerezyme
  3. How Cerezyme is given
  4. Possible side effects
  5. How to store Cerezyme
  1. Contents of the pack and other information

1. What is Cerezyme and what is it used for

Cerezyme contains the active substance imiglucerase and is used to treat patients with confirmed diagnosis of Gaucher disease type I or III who show signs of the disease such as: anaemia (lack of red blood cells), tendency to bleed easily (due to lack of platelets, a type of blood cell), enlargement of the spleen or liver or bone disease (bone disease).

People with Gaucher disease have low levels of an enzyme called acid beta-glucosidase. This enzyme helps the body to control levels of glucocerebroside. Glucocerebroside is a natural substance in the body made up of sugar and fat. When you have Gaucher disease, levels of glucocerebroside can be too high.

Cerezyme is made up of an artificial enzyme called imiglucerase that can replace the natural enzyme acid beta-glucosidase that is lacking or not active enough in patients with Gaucher disease.

The information in this leaflet applies to all patient groups, including children, adolescents, adults and the elderly.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Cerezyme

Do not use Cerezyme

  • if you are allergic to imiglucerase or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before you start using Cerezyme:

  • if you are being treated with Cerezyme, you may have an allergic reaction while you are being given the medicine or soon after. If you have this type of reaction, you should tell your doctor immediately. Your doctor will check if you have an allergic reaction to imiglucerase.
    • some patients with Gaucher disease have high blood pressure in the lungs (pulmonary hypertension). The cause may be unknown or due to heart, lung or liver problems. This can happen whether or not you are being treated with Cerezyme. However, if you have difficulty breathing, you should tell your doctor.

Other medicines and Cerezyme

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Cerezyme must not be given mixed with other medicines in the same infusion (drip).

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Cerezyme should be used with caution during pregnancy and breast-feeding.

Cerezyme contains sodium

This medicine contains 41 mg of sodium (main component of cooking/table salt) in each vial. This is equivalent to 2% of the maximum daily intake of sodium recommended for an adult. It is given through an intravenous solution of sodium chloride at 0.9%. This should be taken into account in patients on a low-sodium diet.

3. How Cerezyme is given

Instructions for proper use

Cerezyme is given through a drip connected to a vein (through intravenous infusion).

It is supplied as a powder to be mixed with sterile water before administration.

Cerezyme can only be given under the supervision of a doctor who is familiar with the treatment of Gaucher disease. Your doctor may suggest that you follow the treatment at home if you meet certain criteria. Contact your doctor if you wish to receive treatment at home.

The dose you receive will be specific to you. Your doctor will adjust the dose based on the severity of your symptoms, among other factors. The recommended dose is 60 units/kg body weight given every two weeks.

Your doctor will closely monitor your response to treatment and may change your dose (increase or decrease) until the best dose to control your symptoms is found.

Once this dose is determined, your doctor will check your response to make sure you are using the right dose, probably every 6-12 months.

There is no information on the effect of Cerezyme on the cerebral symptoms of patients with chronic neuropathic Gaucher disease. Therefore, a special dosage regimen cannot be recommended.

ICGG Gaucher Registry

Your doctor may ask you to register your patient data in the "ICGG Gaucher Registry" (ICGG: International Collaborative Gaucher Group). The purpose of this registry is to expand knowledge about Gaucher disease and to check the functioning of enzyme replacement therapy, such as Cerezyme. This should lead to improved safety and efficacy of the use of Cerezyme. Your patient data will be recorded anonymously: no one will know that it is your data.

If you use more Cerezyme than you should

No cases of overdose with Cerezyme have been reported.

If you miss a dose of Cerezyme

If you miss a dose for any reason, contact your doctor.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Common(may affect up to 1 in 10 people):

  • difficulty breathing
  • cough
  • urticaria/localised swelling of the skin or mucous membranes of the mouth or throat
  • pruritus (itching)
  • rash

Uncommon(may affect up to 1 in 100 people):

  • dizziness
  • headache
  • tingling, itching, burning or numbness of the skin
  • increased heart rate
  • cyanosis (blue discoloration) of the skin
  • flushing
  • decreased blood pressure
  • vomiting
  • nausea
  • abdominal colic pain
  • diarrhoea
  • arthralgia (joint pain)
  • discomfort at the infusion site
  • burning sensation at the infusion site
  • swelling at the infusion site
  • sterile abscess at the injection site
  • chest discomfort
  • fever
  • chills
  • fatigue
  • back pain

Rare(may affect up to 1 in 1,000 people):

  • anaphylactoid reactions

Some side effects have been seen mainly while patients were receiving the medicine or soon after. These include itching, flushing, urticaria/localised swelling of the skin or mucous membranes of the mouth or throat, chest discomfort, increased heart rate, cyanosis of the skin, difficulty breathing, tingling, itching, burning or numbness of the skin, decreased blood pressure and back pain. If you experience any of these symptoms, tell your doctor immediately. You may need other medicines to prevent an allergic reaction (e.g. antihistamines and/or corticosteroids).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Cerezyme

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month stated.

Unopened vials: Store in a refrigerator (2°C - 8°C).

Diluted solution:

Cerezyme should be used immediately after mixing with sterile water. The mixed solution in the vial cannot be stored and must be diluted immediately in an infusion bag; the diluted solution can be stored for up to 24 hours if kept cool (2-8°C) and protected from light.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Contents of the pack and other information

What is in Cerezyme

  • The active substance is imiglucerase. Imiglucerase is a modified form of the human enzyme acid beta-glucosidase produced by recombinant DNA technology. Each vial contains 400 units of imiglucerase. After reconstitution, the solution contains 40 units of imiglucerase per millilitre.
  • The other ingredients are: mannitol, sodium citrate, citric acid monohydrate and polysorbate 80.

Appearance of Cerezyme and pack contents

Cerezyme 400 Units is presented as a powder for concentrate for solution for infusion (in a vial – pack size of 1, 5 or 25 vials). Not all pack sizes may be marketed.

Cerezyme is supplied as a white or off-white powder. After reconstitution, it appears as a clear and colourless solution. The reconstituted solution should be further diluted.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Sanofi B.V., Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands

Manufacturer

Genzyme Ireland Limited, IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland

You can get more information on this medicine by contacting the local representative of the Marketing Authorisation Holder:

België/Belgique/Belgien/Luxembourg/Luxemburg

Sanofi Belgium

Tel: + 32 2 710 54 00

Magyarország

SANOFI-AVENTIS Zrt.

Tel: +36 1 505 0050

България

Swixx Biopharma EOOD

Тел.: +359 (0)2 4942 480

Malta

Sanofi S.r.l.

Tel: +39 02 39394275

Ceská republika

sanofi-aventis, s.r.o.

Tel: +420 233 086 111

Nederland

Genzyme Europe B.V.

Tel: +31 20 245 4000

Danmark

Sanofi A/S

Tlf: +45 45 16 70 00

Norge

sanofi-aventis Norge AS

Tlf: + 47 67 10 71 00

Deutschland

Sanofi-Aventis Deutschland GmbH

Tel: 0800 04 36 996

Tel. from abroad: +49 69 305 70 13

Österreich

sanofi-aventis GmbH

Tel: + 43 1 80 185 - 0

Eesti

Swixx Biopharma OÜ

Tel: +372 640 10 30

Polska

sanofi-aventis Sp. z o.o.

Tel.: +48 22 280 00 00

Ελλάδα

sanofi-aventis AEBE

Τηλ: +30 210 900 1600

Portugal

Sanofi – Produtos Farmacêuticos, Lda. Tel: +351 21 35 89 400

España

sanofi-aventis, S.A.

Tel: +34 93 485 94 00

România

Sanofi Romania SRL

Tel: +40 (0) 21 317 31 36

France

sanofi-aventis France

Tél: 0 800 222 555

Appel depuis l’étranger : +33 1 57 63 23 23

Slovenija

Swixx Biopharma d.o.o.

Tel: +386 1 235 51 00

Hrvatska

Swixx Biopharma d.o.o.

Tel: +385 1 2078 500

Slovenská republika

Swixx Biopharma s.r.o.

Tel: +421 2 208 33 600

Ireland

sanofi-aventis Ireland Ltd. T/A SANOFI

Tel: +353 (0) 1 403 56 00

Ísland

Vistor hf.

Sími: +354 535 7000

Suomi/Finland

Sanofi Oy

Puh/Tel: + 358 201 200 300

Italia

Sanofi S.r.l.

Tel: 800 536 389

Sverige

Sanofi AB

Tel: +46 (0)8 634 50 00

Κύπρος

C.A. Papaellinas Ltd.

Τηλ: +357 22 741741

United Kingdom(Northern Ireland)

sanofi-aventis Ireland Ltd. T/A SANOFI

Tel: +44 (0) 800 035 2525

Latvija

Swixx Biopharma SIA

Tel: +371 6 616 47 50

Lietuva

Swixx Biopharma UAB

Tel: +370 5 236 91 40

Date of last revision of this leaflet:

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/. It also provides links to other web sites on rare diseases and their treatments.

-------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Instructions for use: reconstitution, dilution and administration

Each vial of Cerezyme is for single use. After reconstitution, each vial of Cerezyme contains 400 units of imiglucerase in 10.0 ml (40 units per ml).

Determine the number of vials to reconstitute based on the individual patient's dosage, and remove the vials from the refrigerator.

Use aseptic technique

Reconstitution

Reconstitute each vial with 10.2 ml of water for injections, avoiding vigorous impact of the water for injection on the powder and the formation of foam in the solution, mixing gently. The reconstituted volume is 10.6 ml. The pH of the reconstituted solution is approximately 6.2.

After reconstitution, the solution appears as a clear and colourless solution without any visible particles. The reconstituted solution should be further diluted. Before any further dilution, visually inspect the diluted solution in each vial for any visible particles or colour change. Do not use vials that contain visible particles or have changed colour.

After reconstitution, dilute the vials promptly and do not store them for later use.

Dilution

The reconstituted solution contains 40 units of imiglucerase per ml. The reconstituted volume allows for the exact withdrawal of 10.0 ml (equal to 400 units) from each vial. Withdraw 10.0 ml of the reconstituted solution from each vial, combine the withdrawn volumes and further dilute to a total volume of 100 to 200 ml with sodium chloride 0.9% intravenous solution. Mix the infusion solution gently.

Administration

It is recommended to administer the diluted solution through an in-line filter with a pore size of 0.2 µm and low protein binding to remove any particulate matter. This will not cause a decrease in imiglucerase activity. It is recommended to administer the diluted solution within 3 hours. The diluted product in sodium chloride 0.9% solution may retain its chemical stability for up to 24 hours if stored at 2-8°C and protected from light, but microbiological safety will depend on whether reconstitution and dilution are performed aseptically.

Cerezyme does not contain preservatives. Disposal of unused medicine and all materials that have been in contact with it should be done in accordance with local regulations.

Online doctors for CEREZYME 400 units powder for concentrate for infusion solution

Discuss questions about CEREZYME 400 units powder for concentrate for infusion solution, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(1)

Cristina Andrada Brazo

General medicineSleep medicine16 years of experience
Licence no. 264505958

Dr. Cristina Andrada Brazo is a highly experienced Spanish physician with more than 15 years of clinical practice in emergency medicine, urgent care, and clinical neurophysiology. She provides professional online medical consultations for patients across Spain, helping both residents and international visitors receive timely medical advice, diagnosis, treatment recommendations, and electronic prescriptions when clinically appropriate.

As a licensed physician fully integrated with the Spanish electronic prescription system, Dr. Andrada can issue legally valid e-prescriptions following a medical assessment during an online consultation. Whether you need help with an acute illness, prescription renewal, neurological symptoms, or travel-related healthcare, she offers convenient, patient-centered medical care without the need to visit a clinic.

Dr. Andrada combines extensive emergency medicine experience with advanced expertise in neurology, epilepsy, sleep medicine, and headache disorders. Her international clinical background includes several years working in Switzerland, where she collaborated with multidisciplinary teams in emergency departments and neurology services. This experience strengthened her commitment to evidence-based medicine, compassionate communication, and high-quality patient care.

She graduated in Medicine from the University of Seville and completed her residency in Clinical Neurophysiology at Hospital Virgen de la Salud and the National Hospital for Paraplegics in Toledo. She currently works as a Clinical Neurophysiology Specialist at Hospital San Pedro in Logroño.

To further expand her expertise, Dr. Andrada completed several postgraduate qualifications, including Master's degrees in Sleep Physiology and Medicine, Medical Professionalism and Clinical Practice, Epilepsy, and Clinical Management.

Patients appreciate her thorough consultations, practical treatment recommendations, and empathetic approach. She speaks Spanish, French, and Portuguese, allowing her to communicate comfortably with patients from different backgrounds.

Conditions Dr. Cristina Andrada Treats Online

Dr. Andrada provides online consultations for a wide range of common medical conditions, including:

  • Fever, flu, COVID-19 symptoms, sore throat and respiratory infections
  • Sinusitis, bronchitis, cough and seasonal allergies
  • Urinary tract infections (UTIs)
  • Migraine and tension headaches
  • Dizziness and vertigo
  • Epilepsy and seizure follow-up
  • Sleep disorders, including insomnia and circadian rhythm disturbances
  • Heartburn, gastritis, diarrhea and constipation
  • Back pain, muscle injuries and joint pain
  • Minor skin infections and allergic reactions
  • Fatigue and general medical assessment
  • Prescription renewals for appropriate chronic treatments
  • Follow-up consultations after surgery or previous medical treatment
  • Travel medicine advice and preventive healthcare
  • Interpretation of laboratory results and medical reports

If your condition requires urgent in-person assessment or emergency care, Dr. Andrada will advise you on the most appropriate next steps.

Book an Online Consultation

Book a secure online consultation with Dr. Cristina Andrada Brazo through Oladoctor and receive professional medical advice from an experienced Spanish physician without leaving home. Online appointments are available for adults throughout Spain, with fast access to medical care and electronic prescriptions whenever clinically indicated.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

CEREZYME 400 units powder for concentrate for infusion solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in CEREZYME 400 units powder for concentrate for infusion solution is imiglucerase. This information helps identify medicines with the same composition but different brand names.

CEREZYME 400 units powder for concentrate for infusion solution is manufactured by Sanofi B.V.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Endocrinologists, Gastroenterologists, Oncologists, Sports medicine specialists, General medicine doctors, Lactation medicine doctors, Intensive care physicians may assess whether CEREZYME 400 units powder for concentrate for infusion solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, CEREZYME 400 units powder for concentrate for infusion solution is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (imiglucerase) include ALDURAZYME, 100 U/mL Concentrate for Infusion Solution, BRINEURA 150 MG SOLUTION FOR INFUSION, ELAPRASE 2 mg/ml CONCENTRATE for SOLUTION for INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media